Janux director granted RSUs and stock options
Janux Therapeutics director Eric Dobmeier received new equity awards.
Rhea-AI Filing Summary
Janux Therapeutics director Eric Dobmeier received new equity awards. He was granted 5,500 restricted stock units, each representing one share of common stock, which will vest on the earlier of June 11, 2027 or the next annual stockholder meeting, subject to continued service.
He was also granted options to buy 15,500 shares of common stock at an exercise price of $13.66 per share, expiring on June 10, 2036. These options vest in equal monthly installments over the 12 months following June 11, 2026 and will in any case be fully vested by the next annual stockholder meeting, subject to continued service. Following these grants, he directly holds 15,481 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 21,000 shares
Grant/Award
2 txns
Insider
DOBMEIER ERIC
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 15,500 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 15,500 contracts (Direct);
Common Stock — 15,481 shares (Direct)
Footnotes (2)
- F1. Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.
- F2. The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.
Key Figures
RSU grant: 5,500 shares
Option grant size: 15,500 shares
Option exercise price: $13.66 per share
+4 more
7 metrics
RSU grant
5,500 shares
Restricted stock units granted to director on June 11, 2026
Option grant size
15,500 shares
Stock options granted on June 11, 2026
Option exercise price
$13.66 per share
Strike price for 15,500 stock options
Option expiration
June 10, 2036
Expiration date of stock options
Common shares held
15,481 shares
Direct common stock holdings after grants
RSU vesting date
June 11, 2027
Latest vesting date, or earlier at next annual meeting
Option vesting period
12 months
Equal monthly vesting after June 11, 2026
Key Terms
restricted stock units ("RSUs"), Stock Option (right to buy), vest, annual meeting of the Issuer's stockholders, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
vest financial
"The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of the Issuer's stockholders financial
"the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service"
exercise price financial
"conversion_or_exercise_price": "13.6600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Janux Therapeutics (JANX) director Eric Dobmeier receive in this Form 4?
Eric Dobmeier received equity compensation consisting of 5,500 restricted stock units and options for 15,500 shares. These awards are part of his director compensation and are subject to multi-year and meeting-based vesting conditions tied to his continued board service.
How do the 5,500 RSUs granted to JANX director Eric Dobmeier vest?
The 5,500 RSUs vest on the earlier of June 11, 2027 or the date of Janux Therapeutics’ next annual stockholder meeting. Vesting is contingent on Dobmeier’s continuous service as of the applicable date, aligning his incentives with the company’s long-term performance.
What are the key terms of Eric Dobmeier’s 15,500 JANX stock options?
Dobmeier’s options cover 15,500 shares of Janux common stock with a $13.66 exercise price and a June 10, 2036 expiration. They vest in equal monthly installments over 12 months after June 11, 2026, or fully by the next annual meeting, subject to continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
